| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 41 |
| 1 | INFLIXIMAB | 39 |
| 2 | PREDNISOLONE | 38 |
| 3 | PREDNISOLONE ORAL | 38 |
| 4 | PREDNISOLONE ORAL SOLUTION | 38 |
| 5 | EVEROLIMUS | 34 |
| 6 | METHOTREXATE SODIUM | 32 |
| 7 | METHOTREXATE | 29 |
| 8 | VALSARTAN | 27 |
| 9 | FUROSEMIDE | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOREMIFENE CITRATE | 2 | 0.0046 |
| 1 | EPINASTINE HYDROCHLORIDE | 2 | 0.0018 |
| 2 | GOLIMUMAB | 18 | 0.0014 |
| 3 | BISACODYL 5MG | 1 | 0.0011 |
| 4 | EVEROLIMUS | 34 | 0.0007 |
| 5 | EXEMESTANE | 13 | 0.0006 |
| 6 | GADOTERATE MEGLUMINE | 2 | 0.0005 |
| 7 | GADOBENATE DIMEGLUMINE | 2 | 0.0005 |
| 8 | TEMSIROLIMUS | 2 | 0.0004 |
| 9 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 59 |
| 1 | Corticosteroid [EPC] | 54 |
| 2 | Kinase Inhibitor [EPC] | 47 |
| 3 | Angiotensin 2 Receptor Blocker [EPC] | 34 |
| 4 | mTOR Inhibitor Immunosuppressant [EPC] | 34 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 29 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 20 |
| 7 | Loop Diuretic [EPC] | 19 |
| 8 | Aromatase Inhibitor [EPC] | 18 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 1 | Phosphodiesterase 3 Inhibitor [EPC] | 2 | 0.0003 |
| 2 | Estrogen Receptor Antagonist [EPC] | 12 | 0.0003 |
| 3 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 2 | 0.0003 |
| 4 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 5 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 6 | Bile Acid [EPC] | 5 | 0.0002 |
| 7 | Chloride Channel Activator [EPC] | 2 | 0.0002 |
| 8 | Orexin Receptor Antagonist [EPC] | 3 | 0.0002 |
| 9 | Aromatase Inhibitor [EPC] | 18 | 0.0002 |